Financhill
Back

Akero Therapeutics Stock Predictions

Akero Therapeutics Stock Forecast

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 54.7% based on the past 5 years of stock performance.
  • Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Akero Therapeutics Stock Undervalued?
    The current Akero Therapeutics [AKRO] share price is $54.21. The Score for AKRO is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Akero Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 54.7% based on the past 5 years of stock performance.

Akero Therapeutics Stock Rating

Buy
78
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics overpriced?

  • Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Akero Therapeutics Stock Price History

Is AKRO stock going to rise?

  • The current trend is moderately bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com

52-Week Data

52-Week High:
58.40
52-Week Low:
17.86

Prediction Charts

Market Cap:
3.8B
Price in USD:
54.21
Volume:
844.4K
Beta:
-0.15

Technical Analysis

SMA50:
33.44
SMA100:
31.66
SMA200:
27.56
52-Wk Change:
203.02%

Stock Predictions

  • Is Akero Therapeutics stock public?
    Yes, Akero Therapeutics is a publicly traded company.
  • What is the Akero Therapeutics stock quote today?
    The Akero Therapeutics stock price is 54.21 USD today.
  • How to buy Akero Therapeutics stock online?
    You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-21 25.60 25.60 26.20 25.25
Jan-22 25.60 25.02 25.96 24.73
Jan-23 24.77 26.16 26.23 24.69
Jan-24 26.11 26.18 26.47 25.69
Jan-27 57.26 51.71 58.40 48.47
Jan-28 54.63 51.47 57.48 49.38
Jan-29 52.48 54.00 55.74 51.79
Jan-30 55.74 55.36 57.51 54.66
Jan-31 54.82 54.08 55.88 52.89
Feb-3 53.77 53.85 54.69 52.63
Feb-4 53.60 56.41 57.25 53.60
Feb-5 56.87 57.56 57.66 55.60
Feb-6 57.12 54.95 57.78 54.32
Feb-7 54.81 54.21 55.32 53.88

Akero Therapeutics Earnings

Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Akero Therapeutics Forecast Revenue Growth

Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.10 per share.

* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.